Bioengineered organs are no longer just structural substitutes. A review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) platforms—living ...

The acquisition of Miromatrix Medical aims to give United Therapeutics' organ manufacturing programs "additional shots on goal," according to United CEO Martine Rothblatt. (Getty Images) United ...

In a recent press release, CareDx Inc., based in Brisbane, CA, and Miromatrix Medical Inc., based in Eden Prairie, MN, announced a collaboration focused on researching bioengineered organs for human ...

Please provide your email address to receive an email when new articles are posted on . CareDx intends to develop a testing solution to use in pre-clinical animal models. CareDx will provide ...

This press release includes forward-looking statements related to CareDx, Inc., including statements regarding the potential benefits and results that may be achieved with CareDx’s partnership with ...

BROOKLYN, N.Y., April 2, 2025 /PRNewswire/ -- Xylyx Bio, Inc., a regenerative medicine company, announced that it has received $1,000,000 from the Richard M. Bartlett Jr. Memorial Foundation and ...

As the field of bioengineering continues to advance, scientists are making significant strides in growing organs for transplants. Among the most promising developments is the growth of lungs in the ...

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. CareDx, Inc. (Nasdaq: CDNA) and Miromatrix Medical Inc.(Nasdaq: MIRO) – today announced ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CareDx, Inc. CDNA and Miromatrix Medical Inc. ("Miromatrix") MIRO – today announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable human ...

CareDx will develop an innovative testing solution for Miromatrix to use in pre-clinical animal models and will be the exclusive provider of donor-derived cell-free DNA (dd-cfDNA) testing services for ...